4-(2-Chloroacetyl)-N-phenylpiperazine-1-carboxamide

Catalog No.: 
ACMTAR367
CAS No.: 
923125-02-4
Molecular Formula: 
C13H16ClN3O2
Molecular Weight: 
281.74
4-(2-Chloroacetyl)-N-phenylpiperazine-1-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$104.00InquiryInquiry
250mg95%$203.00InquiryInquiry
1g95%$390.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-Chloroacetyl)-N-phenylpiperazine-1-carboxamide
IUPAC Name4-(2-chloroacetyl)-N-phenylpiperazine-1-carboxamide
MDL No.MFCD08444180
Molecular FormulaC13H16ClN3O2
Molecular Weight281.74
SMILESO=C(N1CCN(C(CCl)=O)CC1)NC2=CC=CC=C2
InChI KeyHCMUFRJGPVGTSD-UHFFFAOYSA-N
Synonym4-[OXO(PIPERAZIN-1-YL)ACETYL]MORPHOLINE;4-(2-chloroacetyl)-N-phenylpiperazine-1-carboxamide;1-Piperazinecarboxamide, 4-(2-chloroacetyl)-N-phenyl-;4-(2-Chloroacetyl)-N-phenyl-1-piperazinecarboxamide
CAS No.923125-02-4

Synthetic Route by SureRoute

1. ACMTAR367 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZEQS620 route compound structure diagram
    ACZEQS620115994-87-1In Stock
  4. Then
  5. ACMTAR367 route product structure diagram
    ACMTAR367923125-02-4
Inquiry

2. ACMTAR367 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZEQS620 route compound structure diagram
    ACZEQS620115994-87-1In Stock
  4. Then
  5. ACMTAR367 route product structure diagram
    ACMTAR367923125-02-4
Inquiry

3. ACMTAR367 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMTAR367 route product structure diagram
    ACMTAR367923125-02-4
Inquiry

Comments (0)